1. Home
  2. BLCO vs BYD Comparison

BLCO vs BYD Comparison

Compare BLCO & BYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • BYD
  • Stock Information
  • Founded
  • BLCO 1853
  • BYD 1973
  • Country
  • BLCO Canada
  • BYD United States
  • Employees
  • BLCO N/A
  • BYD N/A
  • Industry
  • BLCO Ophthalmic Goods
  • BYD Hotels/Resorts
  • Sector
  • BLCO Health Care
  • BYD Consumer Discretionary
  • Exchange
  • BLCO Nasdaq
  • BYD Nasdaq
  • Market Cap
  • BLCO 7.0B
  • BYD 5.9B
  • IPO Year
  • BLCO 2022
  • BYD 1993
  • Fundamental
  • Price
  • BLCO $19.51
  • BYD $71.63
  • Analyst Decision
  • BLCO Buy
  • BYD Buy
  • Analyst Count
  • BLCO 11
  • BYD 14
  • Target Price
  • BLCO $21.30
  • BYD $91.38
  • AVG Volume (30 Days)
  • BLCO 477.2K
  • BYD 972.3K
  • Earning Date
  • BLCO 10-30-2024
  • BYD 10-24-2024
  • Dividend Yield
  • BLCO N/A
  • BYD 0.95%
  • EPS Growth
  • BLCO N/A
  • BYD N/A
  • EPS
  • BLCO N/A
  • BYD 5.22
  • Revenue
  • BLCO $4,684,000,000.00
  • BYD $3,843,691,000.00
  • Revenue This Year
  • BLCO $17.44
  • BYD $5.12
  • Revenue Next Year
  • BLCO $6.18
  • BYD $0.69
  • P/E Ratio
  • BLCO N/A
  • BYD $13.74
  • Revenue Growth
  • BLCO 18.01
  • BYD 3.69
  • 52 Week Low
  • BLCO $13.16
  • BYD $49.34
  • 52 Week High
  • BLCO $21.69
  • BYD $74.78
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 44.49
  • BYD 57.60
  • Support Level
  • BLCO $19.31
  • BYD $70.62
  • Resistance Level
  • BLCO $20.23
  • BYD $74.78
  • Average True Range (ATR)
  • BLCO 0.48
  • BYD 1.25
  • MACD
  • BLCO -0.13
  • BYD -0.34
  • Stochastic Oscillator
  • BLCO 5.48
  • BYD 52.52

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About BYD Boyd Gaming Corporation

Boyd Gaming Corp is a multi-jurisdictional gaming company. The company operates wholly-owned gaming entertainment properties (casino space, slot machines, table games, and hotel rooms) in Nevada, Illinois, Indiana, Iowa, Kansas, Louisiana, Mississippi, Missouri, Ohio, and Pennsylvania. Geographical regions separate its business segments: Las Vegas Locals, Downtown Las Vegas, Midwest and South, and Online. Midwest and South hold the key number of entertainment properties, and it generate the majority of sales for the company.

Share on Social Networks: